Lupin gains USFDA approval for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension EP News Bureau Jan 24, 2025 The fixed-dose combination is indicated for the treatment of HIV-1 infection in pediatric patients aged at least 3 months and…
